Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Longhorn Vaccines and Diagnostics LLC
Street 1: 2 Bethesda Metro Center Suite 910
Street 2:
City: Bethesda
Province:
Post Code: 20814
Country: United States of America
Phone: 301-233-1551
Organization Email: jeff@lhnvd.com
Web Site: http://www.lhnvd.com
Other Online Presence:

Focal Point Contact Information

Salutation: Mr.
First Name: Jeff
Last Name: Fischer
Title: CFO
Email: jeff@lhnvd.com
Phone:  

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: Chris
Last Name: Helm
Title:  
Email: chris@lhnvd.com
Phone:  

General Information

Board Constituency: Private sector
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
Longhorn has developed and marketed an advanced collection system for tuberculosis and other pathogens, improving the safety and sensitivity of molecular testing of tuberculosis. Our goal is to open up testing to millions of people world wide where current technology cannot reach and allow their samples to be safely sent to a lab for testing.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Provision of drugs, diagnostics and commodities
Research and Development

Other Organization Information

Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
 
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We are not working on the US control plan, but are working to help other Countries with their national TB control plans.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
South Africa

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Developing components for sequencing drug resistance.

TB-HIV:
Developing more sensitive tests for diagnosing TB in HIV positive patients

Laboratory Strengthening:
Providing technology to improve safety in specimen handling

New Diagnostics:
Developing more sensitive molecular tests for TB

New TB Drugs:
Developing therapeutics to affect TB bacteremia.

Declaration

Declaration of interests:
No conflicts

Application date: January 31, 2016
Last updated: February 8, 2016